Trial on the Impact of Indirect Calorimetry-Guided Nutritional Support on Patient-Centered Outcomes in Critically Ill Patients - The OPTICal Study

NCT ID: NCT07343440

Last Updated: 2026-01-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

356 participants

Study Classification

INTERVENTIONAL

Study Start Date

2026-01-01

Study Completion Date

2027-09-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This multicentric randomized controlled trial aims to evaluate whether indirect calorimetry (IC)-guided nutritional support improves patient-centered outcomes in critically ill adult patients compared to standard formula-based nutritional strategies. The study includes mechanically ventilated patients expected to remain in the ICU for more than 72 hours. The intervention group will receive nutritional targets based on measured resting energy expenditure using the QNRG+ device, with a gradual escalation of energy delivery following current ESPEN guidelines. The primary outcome is quality of life at 3 months post-ICU admission, assessed using the EQ-5D-5L. Secondary outcomes include functional recovery, muscle preservation, infection rates, and rehospitalization. This study is the first to assess the long-term impact of IC-guided nutrition on recovery and quality of life using a patient-centered approach.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Critical Illness ICU

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intervention Group - Indirect Calorimetry Group

Group Type EXPERIMENTAL

Indirect Calorimetry Group

Intervention Type OTHER

* Nutritional targets measured by IC starting on Day 4
* Repeated IC measurements 2 times weekly performed with the QNRG+ device
* Gradual escalation to 80%-100% caloric coverage by Day 4

Control Group - Formula-Based Group

Group Type ACTIVE_COMPARATOR

Control Group - Formula-Based Group

Intervention Type OTHER

* Nutritional targets determined using predictive equations (pragmatic, set at local level)
* Escalation as per local protocol

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Indirect Calorimetry Group

* Nutritional targets measured by IC starting on Day 4
* Repeated IC measurements 2 times weekly performed with the QNRG+ device
* Gradual escalation to 80%-100% caloric coverage by Day 4

Intervention Type OTHER

Control Group - Formula-Based Group

* Nutritional targets determined using predictive equations (pragmatic, set at local level)
* Escalation as per local protocol

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

All patients admitted to the ICU with the following criteria:

* ≥18 years old
* On Mechanical Ventilation
* Expected ICU length of stay \>72 hours

Exclusion Criteria

* Refusal of the family or patient
* Patient transferred from another ICU
* Pregnant patient
* Patient is planned for a withdrawal of care or is actively dying
* Cognitive disorder before ICU
* Patient is in jail
* Patients already enrolled in the ongoing NutriPhyT trial
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Zürich

OTHER

Sponsor Role collaborator

GHOL Nyon Hospital

UNKNOWN

Sponsor Role collaborator

HEIDEGGER CP

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

HEIDEGGER CP

Prof

Responsibility Role SPONSOR_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Geneva University Hospital

Geneva, , Switzerland

Site Status

GHOL

Nyon, , Switzerland

Site Status

Zürich University Hospitals

Zurich, , Switzerland

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Switzerland

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Claudia Paula Heidegger, Prof.

Role: CONTACT

+41223727440

Aude de Watteville, MSc

Role: CONTACT

+41795533998

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Claudia Paula Heidegger, Prof.

Role: primary

+41223727440

Aude de Watteville, MSc

Role: backup

+41795533998

Mallory Moret, Dr. med.

Role: primary

+41 (0)22 994 67 47

Mattia Müller, Dr. med.

Role: primary

0794184324

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

OPTICal2025

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.